22.626 articles found

Eight years of clinical improvement in MPTP-lesioned primates after gene therapy with AAV2-hAADC.

Hadaczek P, Eberling JL, Pivirotto P, Bringas J, Forsayeth J, Bankiewicz KS.

Mol Ther · 2010-06-08

DOI: 10.1038/mt.2010.106PMID: 20531394

Differences in activation of ERK1/2 and p38 kinase in Jnk3 null mice following KA treatment.

de Lemos L, Junyent F, Verdaguer E, Folch J, Romero R, Pallàs M, Ferrer I, Auladell C, Camins A.

J Neurochem · 2010-06-08

DOI: 10.1111/j.1471-4159.2010.06853.xPMID: 20534003

4 -HYDRAZONO- 1,4 -DIHYDROPYRIDINE DERIVATIVES FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES

HOLZGRABE ULRIKE, ALPTUEZUEN VILDAN.

· 2010-06-07

Melittin useful as a therapeutic agent to relieve symptoms, restore and/or protect neurons from patients with Parkinson's disease

HARTMANN ANDREAS.

· 2010-06-07

Rivastigmine in the treatment of dementia associated with Parkinson's disease: effects on activities of daily living.

Olin JT, Aarsland D, Meng X.

Dement Geriatr Cogn Disord · 2010-06-05

DOI: 10.1159/000305100PMID: 20523050

Costs of Parkinson's disease and antiparkinsonian pharmacotherapy: an Italian cohort study.

Winter Y, von Campenhausen S, Reese JP, Balzer-Geldsetzer M, Longo K, Spiga G, Boetzel K, Eggert K, Oertel WH, Dodel R, Barone P.

Neurodegener Dis · 2010-06-04

DOI: 10.1159/000302644PMID: 20523028

Design, synthesis and biological evaluation of L-dopa amide derivatives as potential prodrugs for the treatment of Parkinson's disease.

Zhou T, Hider RC, Jenner P, Campbell B, Hobbs CJ, Rose S, Jairaj M, Tayarani-Binazir KA, Syme A.

Eur J Med Chem · 2010-06-02

DOI: 10.1016/j.ejmech.2010.05.062PMID: 20646792

COMPOSITIONS AND METHODS FOR TREATMENT OF PARKINSON'S DISEASE

CHUNG SANGMI, KIM KWANG-SOO.

· 2010-06-01

Impact of belief in neuroprotection on therapeutic intervention in Parkinson's disease.

Elble RJ, Suchowersky O, Shaftman S, Weiner WJ, Huang P, Tilley B, NINDS NET-PD Investigators.

Mov Disord · 2010-06-01

DOI: 10.1002/mds.22997PMID: 20131372

Marked improvement of psychotic symptoms after electroconvulsive therapy in Parkinson disease.

Ueda S, Koyama K, Okubo Y.

J ECT · 2010-06-01

DOI: 10.1097/yct.0b013e3181c18a3dPMID: 20386461

FP-CIT SPECT in clinically inconclusive Parkinsonian syndrome during amiodarone treatment: a study with follow-up.

Hambÿe AS, Vervaet A, Dethy S.

Nucl Med Commun · 2010-06-01

DOI: 10.1097/mnm.0b013e328338456ePMID: 20429096

Juvenile parkinsonism: epidemiology, diagnosis and treatment.

Thomsen TR, Rodnitzky RL.

CNS Drugs · 2010-06-01

DOI: 10.2165/11533130-000000000-00000PMID: 20443646